Home > Insider Trading > Filing (0001144204-12-038628)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727207	Accelr8 Technology Corp	AXK	Laboratory Analytical Instruments (3826)	841072256

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1388833	Lawrence Mehren	5661 North Calle Mayapan Tucson AZ 85718	Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-06-26	14,000,000	$1.03	14,000,000	No	4	P	Indirect	Through Abeja Ventures, LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Through Abeja Ventures, LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2012-06-26	2,200,000	$0.00	2,200,000	$1.04
Common Stock	Warrants (right to buy)	Acquisiton	2012-06-26	7,000,000	$0.00	7,000,000	$1.03
Common Stock	Warrants (right to buy)	Acquisiton	2012-06-26	7,000,000	$0.00	7,000,000	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,200,000		2022-04-20	No	4	A	Direct
9,200,000	2012-06-26	2017-06-26	No	4	P	Indirect
16,200,000	2012-06-26	2017-06-26	No	4	P	Indirect

Footnotes

The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The option was granted by the company's compensation committee on April 20, 2012, subject to shareholder approval, which was subsequently obtained on June 26, 2012. THe exercise price of the option is equal to the closing price of the company's common stock on the grant date. The option is exercisable over a period of time in accordance with the vesting schedule set forth in the applicable award agreement.